Phase I Study Protocol: NKTR-255 as Monotherapy or Combined with Daratumumab or Rituximab in Hematologic MalignanciesNina Shah, Krina K. Patel, Miguel‐Angel Perales et al.|Future Oncology|2021Cited by 21
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapyRajshekhar Chakraborty, Eli Muchtar, Saurabh Zanwar et al.|Blood|2024Cited by 18
SEETrials: Leveraging large language models for safety and efficacy extraction in oncology clinical trialsKyeryoung Lee, Xiaoyan Wang, Surabhi Datta et al.|Informatics in Medicine Unlocked|2024Cited by 12
Seetrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical TrialsKyeryoung Lee, Xiaoyan Wang, Hunki Paek et al.|SSRN Electronic Journal|2024Cited by 5
SEETrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical TrialsKyeryoung Lee, Xiaoyan Wang, Hunki Paek et al.|medRxiv|2024Cited by 4